Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis
Abstract Systemic lupus erythematosus (SLE), a severe autoimmune disorder, is characterized by systemic inflammatory response, autoantibody accumulation and damage to organs. The dysregulation of double-negative (DN) T cells is considered as a crucial commander during SLE. Neddylation, a significant...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2024-01-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-023-01709-9 |
| _version_ | 1797349636819648512 |
|---|---|
| author | Yun Zhang Lijun Du Chenxi Wang Zhangsheng Jiang Qingchi Duan Yiping Li Zhijun Xie Zhixing He Yi Sun Lin Huang Liwei Lu Chengping Wen |
| author_facet | Yun Zhang Lijun Du Chenxi Wang Zhangsheng Jiang Qingchi Duan Yiping Li Zhijun Xie Zhixing He Yi Sun Lin Huang Liwei Lu Chengping Wen |
| author_sort | Yun Zhang |
| collection | DOAJ |
| description | Abstract Systemic lupus erythematosus (SLE), a severe autoimmune disorder, is characterized by systemic inflammatory response, autoantibody accumulation and damage to organs. The dysregulation of double-negative (DN) T cells is considered as a crucial commander during SLE. Neddylation, a significant type of protein post-translational modification (PTM), has been well-proved to regulate T cell-mediated immune response. However, the function of neddylation in SLE is still unknown. Here, we reported that neddylation inactivation with MLN4924, a specific inhibitor of NEDD8-activating enzyme E1 (NAE1), or genetic abrogation of Ube2m in T cells decreased DN T cell accumulation and attenuated murine lupus development. Further investigations revealed that inactivation of neddylation blocked Bim ubiquitination degradation and maintained Bim level in DN T cells, contributing to the apoptosis of the accumulated DN T cells in lupus mice. Then double knockout (KO) lupus-prone mice (Ube2m -/- Bim -/- lpr) were generated and results showed that loss of Bim reduced Ube2m deficiency-induced apoptosis in DN T cells and reversed the alleviated lupus progression. Our findings identified that neddylation inactivation promoted Bim-mediated DN T cell apoptosis and attenuated lupus progression. Clinically, we also found that in SLE patients, the proportion of DN T cells was raised and their apoptosis was reduced. Moreover, compared to healthy groups, SLE patients exhibited decreased Bim levels and elevated Cullin1 neddylation levels. Meantime, the inhibition of neddylation induced Bim-dependent apoptosis of DN T cells isolated from SLE patients. Altogether, our findings provide the direct evidence about the function of neddylation during lupus, suggesting a promising therapeutic approach for this disease. |
| first_indexed | 2024-03-08T12:33:10Z |
| format | Article |
| id | doaj.art-40ce9ddb45c44ec78cf6f56cef011994 |
| institution | Directory Open Access Journal |
| issn | 2059-3635 |
| language | English |
| last_indexed | 2024-03-08T12:33:10Z |
| publishDate | 2024-01-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Signal Transduction and Targeted Therapy |
| spelling | doaj.art-40ce9ddb45c44ec78cf6f56cef0119942024-01-21T12:37:04ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352024-01-019111310.1038/s41392-023-01709-9Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasisYun Zhang0Lijun Du1Chenxi Wang2Zhangsheng Jiang3Qingchi Duan4Yiping Li5Zhijun Xie6Zhixing He7Yi Sun8Lin Huang9Liwei Lu10Chengping Wen11Key Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical UniversityKey Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical UniversityKey Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical UniversityKey Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical UniversityKey Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical UniversityKey Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical UniversityKey Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical UniversityKey Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical UniversityCancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education) of the Second Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of MedicineKey Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical UniversityDepartment of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong KongKey Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical UniversityAbstract Systemic lupus erythematosus (SLE), a severe autoimmune disorder, is characterized by systemic inflammatory response, autoantibody accumulation and damage to organs. The dysregulation of double-negative (DN) T cells is considered as a crucial commander during SLE. Neddylation, a significant type of protein post-translational modification (PTM), has been well-proved to regulate T cell-mediated immune response. However, the function of neddylation in SLE is still unknown. Here, we reported that neddylation inactivation with MLN4924, a specific inhibitor of NEDD8-activating enzyme E1 (NAE1), or genetic abrogation of Ube2m in T cells decreased DN T cell accumulation and attenuated murine lupus development. Further investigations revealed that inactivation of neddylation blocked Bim ubiquitination degradation and maintained Bim level in DN T cells, contributing to the apoptosis of the accumulated DN T cells in lupus mice. Then double knockout (KO) lupus-prone mice (Ube2m -/- Bim -/- lpr) were generated and results showed that loss of Bim reduced Ube2m deficiency-induced apoptosis in DN T cells and reversed the alleviated lupus progression. Our findings identified that neddylation inactivation promoted Bim-mediated DN T cell apoptosis and attenuated lupus progression. Clinically, we also found that in SLE patients, the proportion of DN T cells was raised and their apoptosis was reduced. Moreover, compared to healthy groups, SLE patients exhibited decreased Bim levels and elevated Cullin1 neddylation levels. Meantime, the inhibition of neddylation induced Bim-dependent apoptosis of DN T cells isolated from SLE patients. Altogether, our findings provide the direct evidence about the function of neddylation during lupus, suggesting a promising therapeutic approach for this disease.https://doi.org/10.1038/s41392-023-01709-9 |
| spellingShingle | Yun Zhang Lijun Du Chenxi Wang Zhangsheng Jiang Qingchi Duan Yiping Li Zhijun Xie Zhixing He Yi Sun Lin Huang Liwei Lu Chengping Wen Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis Signal Transduction and Targeted Therapy |
| title | Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis |
| title_full | Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis |
| title_fullStr | Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis |
| title_full_unstemmed | Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis |
| title_short | Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis |
| title_sort | neddylation is a novel therapeutic target for lupus by regulating double negative t cell homeostasis |
| url | https://doi.org/10.1038/s41392-023-01709-9 |
| work_keys_str_mv | AT yunzhang neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis AT lijundu neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis AT chenxiwang neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis AT zhangshengjiang neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis AT qingchiduan neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis AT yipingli neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis AT zhijunxie neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis AT zhixinghe neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis AT yisun neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis AT linhuang neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis AT liweilu neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis AT chengpingwen neddylationisanoveltherapeutictargetforlupusbyregulatingdoublenegativetcellhomeostasis |